Starpharma Holdings Limited
ASX: SPL.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Cheryl Maley
- Employees
- 40
- Headquarters
- Abbotsford, Australia
- IPO year
- 2000
- Market cap
- A$303.1M
- Website
- https://starpharma.com
Loading SPL…
Loading profile data…Frequently asked questions about SPL
What does Starpharma Holdings Limited (SPL.AX) do?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel cond...
Where does SPL.AX trade?
Starpharma Holdings Limited (SPL.AX) trades on the Australian Securities Exchange.
What sector is SPL.AX in?
Starpharma Holdings Limited (SPL.AX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Starpharma Holdings Limited?
Cheryl Maley is the chief executive officer of Starpharma Holdings Limited (SPL.AX).
Where is Starpharma Holdings Limited headquartered?
Starpharma Holdings Limited is headquartered in Australia.
Does SPL.AX pay a dividend?
Starpharma Holdings Limited (SPL.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPL.AX go public?
Starpharma Holdings Limited (SPL.AX) completed its initial public offering in 2000.